Abstract is: Anthony David FMedSci is a British neuropsychiatrist based at University College London. Previously tenured as professor of cognitive neuropsychiatry and Vice Dean at the Institute of Psychiatry, King's College London, since 2018 he has been Director, University College London, Institute of Mental Health. He is the father of Rebecca David, a Senior Campaign Manager at Influencer LTD and Michael David a junior doctor.
| human | Q5 |
| P166 | award received | Fellow of the Academy of Medical Sciences | Q24081923 |
| Fellow of the Royal College of Physicians of London | Q26204035 | ||
| P27 | country of citizenship | United Kingdom | Q145 |
| P69 | educated at | University of London | Q170027 |
| University of Glasgow | Q192775 | ||
| P108 | employer | University College London | Q193196 |
| Institute of Psychiatry, Psychology and Neuroscience | Q631045 | ||
| King's College London | Q245247 | ||
| P734 | family name | David | Q12652673 |
| David | Q12652673 | ||
| David | Q12652673 | ||
| P735 | given name | Anthony | Q12241622 |
| Anthony | Q12241622 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | researcher | Q1650915 |
| neuropsychiatrist | Q19826744 | ||
| P21 | sex or gender | male | Q6581097 |
| Q36148525 | A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups |
| Q95599113 | A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT RCT |
| Q68458104 | Agenesis of the corpus callosum and schizophrenia: a case report |
| Q34543157 | An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis |
| Q37451462 | Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation |
| Q38438472 | Brain activation during automatic and controlled processing of semantic relations: a priming experiment using lexical-decision |
| Q46888485 | Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis |
| Q57403269 | Cannabis users have higher premorbid IQ than other patients with first onset psychosis |
| Q38473844 | Categorical-semantic and spatial-imagery judgements of non-verbal stimuli in the cerebral hemispheres |
| Q64355333 | Characteristics of patients with motor functional neurological disorder in a large UK mental health service: a case–control study |
| Q37367834 | Clinical assessment of decision-making capacity in acquired brain injury with personality change |
| Q93135009 | Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode |
| Q36867388 | Cognitive load and autonomic response patterns under negative priming demand in depersonalization-derealization disorder |
| Q57403275 | Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users |
| Q39070362 | Connectomic correlates of response to treatment in first-episode psychosis. |
| Q39366868 | Cortical folding defects as markers of poor treatment response in first-episode psychosis |
| Q57403242 | Cortical thickness correlates of minor neurological signs in patients with first episode psychosis |
| Q34322915 | Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users |
| Q33389913 | Delusion formation and insight in the context of affective disturbance |
| Q34272839 | Depersonalisation disorder: a cognitive–behavioural conceptualisation |
| Q33750897 | Depersonalization: A selective impairment of self-awareness |
| Q44844254 | Diagnostic criteria in schizophrenia: accentuate the positive |
| Q57403231 | Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients |
| Q47976367 | Dissociable brain correlates for depression, anxiety, dissociation, and somatization in depersonalization-derealization disorder |
| Q47852123 | Do psychosis patients with poor insight show implicit awareness on the emotional stroop task? |
| Q55040139 | Dynamical features in fetal and postnatal zinc-copper metabolic cycles predict the emergence of autism spectrum disorder. |
| Q92196809 | Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study |
| Q47702704 | Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study. |
| Q92861621 | Epidemiology of functional stroke mimic patients: a systematic review and meta-analysis |
| Q34095943 | Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study |
| Q98501040 | Experiences and Illness Perceptions of Patients with Functional Symptoms Admitted to Hyperacute Stroke Wards: A Mixed-Method Study |
| Q48223050 | Exploring the predictors of early readmission to psychiatric hospital. |
| Q35813619 | Frontal lobology--psychiatry's new pseudoscience |
| Q48292727 | Functional neurological disorder: psychiatry's blind spot |
| Q37308713 | Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification |
| Q57403321 | Grey matter abnormalities in first-episode schizophrenia and affective psychosis |
| Q35569864 | Illness and insight |
| Q36580001 | Impact of Different Childhood Adversities on 1-Year Outcomes of Psychotic Disorder in the Genetics and Psychosis Study |
| Q35019136 | Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial |
| Q48594983 | Increased inferior frontal activation during word generation: a marker of genetic risk for schizophrenia but not bipolar disorder? |
| Q112645968 | Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study |
| Q118728089 | Inflammatory and blood gas markers of COVID-19 delirium compared to non-COVID-19 delirium: a cross-sectional study |
| Q91102234 | Insight and psychosis: the next 30 years |
| Q59653000 | Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression |
| Q91785444 | Insight is a useful construct in clinical assessments if used wisely |
| Q48102908 | Insight, grey matter and cognitive function in first-onset psychosis |
| Q42676937 | Insight: Demographic Differences and Associations with One-Year Outcome in Schizophrenia and Schizoaffective Disorder |
| Q33626357 | Interoceptive-reflective regions differentiate alexithymia traits in depersonalization disorder |
| Q48170868 | Limbic and prefrontal responses to facial emotion expressions in depersonalization |
| Q57403233 | Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis |
| Q48741994 | Multiple clinical traits predict clinical diagnosis of depersonalization disorder: implications for DSM-V. |
| Q118728092 | Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis |
| Q38608004 | Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme |
| Q89946801 | Outcome measurement in functional neurological disorder: a systematic review and recommendations |
| Q30953030 | Overcoming the effects of false positives and threshold bias in graph theoretical analyses of neuroimaging data |
| Q41597228 | Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study |
| Q50982859 | Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease. |
| Q37302515 | Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls |
| Q34493623 | Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study |
| Q39280839 | Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring |
| Q36010470 | Quantitative analysis of commensal Escherichia coli populations reveals host-specific enterotypes at the intra-species level |
| Q47154405 | Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT). |
| Q47098175 | Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion |
| Q48097216 | Review of assessment tools for psychotic-like experiences misses the psychosis-like symptoms semi-structured interview (PLIKSi) in ALSPAC. |
| Q33914245 | Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis |
| Q48873275 | Self-regulation of the anterior insula: Reinforcement learning using real-time fMRI neurofeedback |
| Q33390183 | Sexually dimorphic changes in the amygdala in relation to delusional beliefs in first episode psychosis |
| Q37228290 | Social disadvantage: cause or consequence of impending psychosis? |
| Q48537346 | Stroop effects within and between the cerebral hemispheres: studies in normals and acallosals |
| Q40157599 | Substance use, medication adherence and outcome one year following a first episode of psychosis |
| Q50775342 | Superior intellectual ability in schizophrenia: neuropsychological characteristics. |
| Q46293580 | The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project |
| Q47787286 | The effects of prefrontal cortex transcranial direct current stimulation (tDCS) on food craving and temporal discounting in women with frequent food cravings |
| Q100489994 | Trial Of Neurostimulation In Conversion Symptoms (TONICS): a feasibility randomised controlled trial of transcranial magnetic stimulation for functional limb weakness |
| Q62725700 | Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence |
| Q38654493 | Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis |
| Q37477310 | White matter integrity as a predictor of response to treatment in first episode psychosis |
| Anthony David (neuropsychiatrist) | wikipedia | |
| Anthony David | wikipedia |
Search more.